Detalhe da pesquisa
1.
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment.
J Hepatol
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570034
2.
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
Liver Int
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618972
3.
Supervised enhancer prediction with epigenetic pattern recognition and targeted validation.
Nat Methods
; 17(8): 807-814, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737473
4.
The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer.
J Biol Chem
; 296: 100374, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33548228
5.
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Invest New Drugs
; 39(5): 1375-1382, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856599
6.
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma.
Expert Opin Emerg Drugs
; 26(1): 39-52, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724135
7.
Radiotherapy following intrahepatic progression on immunotherapy in advanced hepatocellular carcinoma.
J Hepatol
; 80(6): e282-e283, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242325
8.
A network approach to exploring the functional basis of gene-gene epistatic interactions in disease susceptibility.
Bioinformatics
; 34(10): 1741-1749, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29329369
9.
Drug development for hepatocellular carcinoma.
Lancet Oncol
; 24(12): 1292-1294, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039988
10.
The combination of ALBI and AFP response: A small step forward in HCC.
Liver Int
; 43(2): 271-273, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680318
11.
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.
Hum Mol Genet
; 21(23): 5209-21, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22936693
12.
Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease.
JTO Clin Res Rep
; 5(4): 100648, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38590729
13.
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment.
Clin Mol Hepatol
; 29(4): 909-923, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226446
14.
The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma.
J Liver Cancer
; 23(2): 262-271, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589044
15.
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.
Curr Oncol
; 29(8): 5489-5507, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005172
16.
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Cancers (Basel)
; 14(6)2022 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326677
17.
The prime time for management of hepatocellular carcinoma in Hong Kong.
Clin Mol Hepatol
; 29(2): 345-348, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907571
18.
Bioinformatics analysis of circulating cell-free DNA sequencing data.
Clin Biochem
; 48(15): 962-75, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25966961
19.
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients.
J Gastroenterol
; 49(10): 1414-20, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24317935
20.
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation.
Genome Biol
; 15(7): 408, 2014 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25074712